We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Appeals Court Orders FDA To Stay ANDA Approval For Neurontin Generic Capsules

Law360 (July 28, 2004, 12:00 AM EDT) -- A federal appeals court has ordered the U.S. Food and Drug Administration to stay final approval of the Alpharma’s generic version of Pfizer's epilepsy treatment Neurontin pending an appeal.

The U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.